Yang Chao

Title: Yang Chao: Innovator in Histone Deacetylase Inhibitors

Introduction

Yang Chao is a prominent inventor based in Nanjing, China. He has made significant contributions to the field of biomedical research, particularly in the development of histone deacetylase (HDAC) inhibitors. His work has implications for the treatment of various diseases related to the dysregulation of HDAC.

Latest Patents

Yang Chao holds a patent for "Histone deacetylase inhibitors and synthetic method thereof and use thereof in manufacture of medicaments." This invention provides HDAC inhibitors represented as Formula I, where Rto Rare is defined in the specification. The patent also outlines methods for synthesizing these compounds and their applications in preparing pharmaceuticals aimed at preventing or treating mammal diseases associated with HDAC dysregulation. He has 1 patent to his name.

Career Highlights

Throughout his career, Yang Chao has worked with notable companies in the biomedical sector. He has been associated with Nanjing Yoko Biomedical R&D Ltd. and Nanjing Xingang Medical Co., Ltd. His experience in these organizations has contributed to his expertise in the development of innovative medical solutions.

Collaborations

Yang Chao has collaborated with several professionals in his field, including Sheng Jiang and Shang Li. These partnerships have enhanced his research and development efforts, leading to advancements in the understanding and application of HDAC inhibitors.

Conclusion

Yang Chao is a key figure in the innovation of histone deacetylase inhibitors, with a focus on their synthesis and application in medicine. His contributions are vital for the ongoing research in treating diseases related to HDAC dysregulation.